Cargando…
Microbiome Restoration by RBX2660 Does Not Preclude Recurrence of Multidrug-Resistant Urinary Tract Infection Following Subsequent Antibiotic Exposure: A Case Report
A 62-year-old woman received RBX2660, an investigational microbiome restoration therapeutic, for recurrent multidrug-resistant (MDR) urinary tract infection (UTI). RBX2660 increased gut microbiome diversity but did not eliminate uropathogen carriage, and MDR UTI recurred after subsequent antibiotic...
Autores principales: | Keen, Eric C, Tasoff, Preston, Hink, Tiffany, Reske, Kimberly A, Burnham, Carey-Ann D, Dantas, Gautam, Kwon, Jennie H, Dubberke, Erik R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052748/ https://www.ncbi.nlm.nih.gov/pubmed/32154322 http://dx.doi.org/10.1093/ofid/ofaa042 |
Ejemplares similares
-
Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial
por: Kwak, Suryang, et al.
Publicado: (2020) -
Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting
por: Jones, Bruce M, et al.
Publicado: (2020) -
Nail Findings in Chikungunya Infection
por: Swaminathan, Priya, et al.
Publicado: (2020) -
A predictive model of the temperature-dependent inactivation of coronaviruses
por: Yap, Te Faye, et al.
Publicado: (2020) -
Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)